Science Applications International (SAIC) 10-Q 8 Dec 16 2017 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Nov. 04, 2016	Nov. 25, 2016
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Nov. 4, 2016
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q3
Trading Symbol	SAIC
Entity Registrant Name	Science Applications International Corporation
Entity Central Index Key	1,571,123
Current Fiscal Year End Date	--02-03
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		43,880,956

CONDENSED AND CONSOLIDATED STAT

CONDENSED AND CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (UNAUDITED) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Nov. 04, 2016	Oct. 30, 2015	Nov. 04, 2016	Oct. 30, 2015
Statement Of Income And Comprehensive Income [Abstract]
Revenues	$ 1,114	$ 1,136	$ 3,424	$ 3,244
Cost of revenues	1,000	1,030	3,084	2,939
Selling, general and administrative expenses	40	41	120	116
Acquisition and integration costs (Note 3)	0	1	10	16
Operating income	74	64	210	173
Interest expense	15	14	41	31
Income before income taxes	59	50	169	142
Provision for income taxes (Note 5)	(17)	(16)	(57)	(53)
Net income	42	34	112	89
Other comprehensive income (loss), net of tax (Note 8)	2	(2)	2	(1)
Comprehensive income	$ 44	$ 32	$ 114	$ 88
Earnings per share (Note 2):
Basic	$ 0.95	$ 0.74	$ 2.51	$ 1.94
Diluted	0.91	0.72	2.43	1.87
Cash dividends paid per share	0.31	0.31	0.93	0.90
Cash dividends declared per share	$ 0.31	$ 0.31	$ 0.93	$ 0.90

CONDENSED AND CONSOLIDATED BALA

CONDENSED AND CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Millions	Nov. 04, 2016	Jan. 29, 2016
Current assets:
Cash and cash equivalents	$ 203	$ 195
Receivables, net	616	635
Inventory, prepaid expenses and other current assets	151	122
Total current assets	970	952
Goodwill	863	860
Intangible assets (net of accumulated amortization of $44 million and $23 million at November 4, 2016 and January 29, 2016, respectively)	206	224
Property, plant, and equipment (net of accumulated depreciation of $124 million and $112 million at November 4, 2016 and January 29, 2016, respectively)	63	71
Other assets	16	15
Total assets	2,118	2,122
Current liabilities:
Accounts payable and accrued liabilities	451	447
Accrued payroll and employee benefits	217	184
Long-term debt, current portion (Note 6)	8	57
Total current liabilities	676	688
Long-term debt, net of current portion (Note 6)	1,038	1,013
Deferred income taxes	10	8
Other long-term liabilities	37	33
Commitments and contingencies (Note 9)
Equity:
Common stock, $.0001 par value, 1 billion shares authorized, 44 million shares and 45 million shares issued and outstanding as of November 4, 2016 and January 29, 2016, respectively	0	0
Additional paid-in capital	121	215
Retained earnings	243	174
Accumulated other comprehensive loss (Note 8)	(7)	(9)
Total equity	357	380
Total liabilities and equity	$ 2,118	$ 2,122

CONDENSED AND CONSOLIDATED BAL4

CONDENSED AND CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - USD ($) $ in Millions	Nov. 04, 2016	Jan. 29, 2016
Statement Of Financial Position [Abstract]
Intangible assets, accumulated amortization	$ 44	$ 23
Property, plant and equipment, accumulated depreciation	$ 124	$ 112
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	44,000,000	45,000,000
Common stock, shares outstanding	44,000,000	45,000,000

CONDENSED AND CONSOLIDATED STA5

CONDENSED AND CONSOLIDATED STATEMENT OF EQUITY (UNAUDITED) - 9 months ended Nov. 04, 2016 - USD ($) shares in Millions, $ in Millions	Total	Shares of Common stock	Additional paid-in capital	Retained earnings	Accumulated other comprehensive loss
Balance, value at Jan. 29, 2016	$ 380		$ 215	$ 174	$ (9)
Balance, shares at Jan. 29, 2016		45
Net income	112			112
Issuances of stock, value	6		6
Issuances of stock, shares		1
Other comprehensive income, net of tax	2				2
Cash dividends of $0.93 per share	(43)			(43)
Stock-based compensation	2		2
Income tax benefits from stock-based compensation	15		15
Repurchases of stock, value	(117)		(117)
Repurchases of stock, shares		(2)
Balance, value at Nov. 04, 2016	$ 357		$ 121	$ 243	$ (7)
Balance, shares at Nov. 04, 2016		44

CONDENSED AND CONSOLIDATED STA6

CONDENSED AND CONSOLIDATED STATEMENT OF EQUITY (UNAUDITED) (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Nov. 04, 2016	Oct. 30, 2015	Nov. 04, 2016	Oct. 30, 2015
Statement Of Stockholders Equity [Abstract]
Cash dividends paid per share	$ 0.31	$ 0.31	$ 0.93	$ 0.90
Cash dividends declared per share	$ 0.31	$ 0.31	$ 0.93	$ 0.90

CONDENSED AND CONSOLIDATED STA7

CONDENSED AND CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Millions	9 Months Ended
	Nov. 04, 2016	Oct. 30, 2015
Cash flows from operating activities:
Net income	$ 112	$ 89
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	41	42
Stock-based compensation expense	25	25
Excess tax benefits from stock-based compensation	(15)	(9)
Loss on extinguishment of debt	2	0
Increase (decrease) resulting from changes in operating assets and liabilities net of the effect of the acquisition:
Receivables	19	(44)
Inventory, prepaid expenses and other current assets	(13)	(5)
Other assets	(1)	1
Accounts payable and accrued liabilities	6	36
Income taxes payable	(2)	0
Accrued payroll and employee benefits	33	(15)
Other long-term liabilities	4	(2)
Total cash flows provided by operating activities	211	118
Cash flows from investing activities:
Change in restricted cash	4	(16)
Expenditures for property, plant, and equipment	(11)	(11)
Asset acquisition	(2)	0
Cash paid for acquisition, net of cash acquired	0	(764)
Total cash flows used in investing activities	(9)	(791)
Cash flows from financing activities:
Dividend payments to stockholders	(41)	(41)
Principal payments on borrowings	(236)	(29)
Issuances of stock	3	3
Stock repurchased and retired or withheld for taxes on equity awards	(137)	(36)
Excess tax benefits from stock-based compensation	15	9
Disbursements for obligations assumed from Scitor acquisition	(5)	(3)
Proceeds from borrowings	209	670
Deferred financing costs	(2)	(17)
Total cash flows (used in) provided by financing activities	(194)	556
Total increase (decrease) in cash and cash equivalents	8	(117)
Cash and cash equivalents at beginning of period	195	301
Cash and cash equivalents at end of period	$ 203	$ 184

Business Overview and Summary o

Business Overview and Summary of Significant Accounting Policies	9 Months Ended
	Nov. 04, 2016
Accounting Policies [Abstract]
Business Overview and Summary of Significant Accounting Policies	Note 1—Business Overview and Summary of Significant Accounting Policies: Overview Science Applications International Corporation (collectively, with its consolidated subsidiaries, the “Company”) is a leading provider of technical, engineering and enterprise information technology (IT) services primarily to the U.S. government. The Company provides engineering and integration services for large, complex projects and offers a broad range of services with a targeted emphasis on higher-end, differentiated technology services. Each of the Company’s operating segments is focused on providing the Company’s comprehensive technical and enterprise IT service offerings to its respective customer base. The Company’s operating segments have been aggregated into one reporting segment for financial reporting purposes. On May 4, 2015, the Company acquired 100% of privately held Scitor Holdings, Inc. (Scitor), a leading provider of technical services to the U.S. intelligence community and other U.S. government customers. Principles of Consolidation and Basis of Presentation The accompanying financial information has been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission for interim reporting purposes. References to “financial statements” refer to the condensed and consolidated financial statements of the Company, which include the statements of income and comprehensive income, balance sheets, statement of equity and statements of cash flows. These financial statements were prepared in accordance with U.S. generally accepted accounting principles (GAAP). All intercompany transactions and account balances within the Company have been eliminated. The financial statements are unaudited, but in the opinion of management include all adjustments, which consist of normal recurring adjustments, necessary for a fair presentation thereof. The results reported in these financial statements are not necessarily indicative of results that may be expected for the entire year and should be read in conjunction with the information contained in the Company’s Annual Report on Form 10-K for the year ended January 29, 2016. Use of Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingencies at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting periods. Significant estimates inherent in the preparation of the financial statements may include, but are not limited to estimated profitability of long-term contracts, income taxes, fair value measurements, fair value of goodwill and other intangible assets, and contingencies. Estimates have been prepared by management on the basis of the most current and best available information at the time of estimation and actual results could differ from those estimates. Changes in estimates of revenues, cost of revenues or profits related to contracts accounted for using the cost-to-cost and efforts expended methods of percentage-of-completion accounting are recognized in operating income in the period in which such changes are made for the inception-to-date effect of the changes. Changes in these estimates can routinely occur over the contract performance period for a variety of reasons, which include: changes in contract scope; changes in contract cost estimates due to unanticipated cost growth or reassessments of risks impacting costs; changes in estimated incentive or award fees; and performance being better or worse than previously estimated. Aggregate changes in contract estimates increased operating income by $5 million ($0.08 per diluted share) and $18 million ($0.26 per diluted share) for the three and nine months ended November 4, 2016, respectively, and increased operating income by $1 million ($0.02 per diluted share) and $9 million ($0.12 per diluted share) for the three and nine months ended October 30, 2015, respectively. Reporting Periods The Company utilizes a 52/53 week fiscal year ending on the Friday closest to January 31, with fiscal quarters typically consisting of 13 weeks. Fiscal 2016 began on January 31, 2015 and ended on January 29, 2016, while fiscal 2017 began on January 30, 2016 and ends on February 3, 2017. The number of weeks for each quarter for fiscal 2017 and 2016 are as follows: Fiscal 2017 Fiscal 2016 (weeks) First Quarter 14 13 Second Quarter 13 13 Third Quarter 13 13 Fourth Quarter 13 13 Fiscal Year 53 52 Operating Cycle The Company’s operating cycle for long-term contracts may be greater than one year and is measured by the average time intervening between the inception and the completion of those contracts. Contract-related assets and liabilities are classified as current assets and current liabilities. Derivative Instruments Designated as Cash Flow Hedges Derivative instruments are recorded on the condensed and consolidated balance sheets at fair value. Unrealized gains and losses on derivatives designated as cash flow hedges are reported in other comprehensive (loss) income and reclassified to earnings in a manner that matches the timing of the earnings impact of the hedged transactions. The ineffective portion of all hedges, if any, is recognized immediately in earnings. The Company’s fixed interest rate swaps are considered over-the-counter derivatives, and fair value is calculated using a standard pricing model for interest rate swaps with contractual terms for maturities, amortization and interest rates. Level 2, or market observable inputs (such as yield and credit curves), are used within the standard pricing models in order to determine fair value. The fair value is an estimate of the amount that the Company would pay or receive as of a measurement date if the agreements were transferred to a third party or canceled. See Note 7 for further discussion on the Company’s derivative instruments designated as cash flow hedges. Accounting Standards Updates In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers (Topic 606) Deferral of the Effective Date In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) Topic 840 Revenue from Contracts with Customers (Topic 606) In March 2016, the FASB issued ASU No. 2016-09, Improvements to Employee Share-Based Payment Accounting In November 2016, the FASB issued ASU No. 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash Other Accounting Standards Updates effective after November 4, 2016 are not expected to have a material effect on the Company’s financial statements.

Earnings Per Share

Earnings Per Share	9 Months Ended
	Nov. 04, 2016
Earnings Per Share [Abstract]
Earnings Per Share	Note 2—Earnings Per Share: Basic earnings per share (EPS) is computed by dividing net income by the basic weighted-average number of shares outstanding. Diluted EPS is computed similarly to basic EPS, except the weighted-average number of shares outstanding is increased to include the dilutive effect of outstanding stock options and other stock-based awards. A reconciliation of the weighted-average number of shares outstanding used to compute basic and diluted EPS was: Three Months Ended Nine Months Ended November 4, 2016 October 30, 2015 November 4, 2016 October 30, 2015 (in millions) Basic weighted-average number of shares outstanding 44.2 46.0 44.6 45.9 Dilutive common share equivalents - stock options and other stock-based awards 1.4 1.4 1.4 1.6 Diluted weighted-average number of shares outstanding 45.6 47.4 46.0 47.5 The following stock-based awards were excluded from the weighted-average number of shares outstanding used to compute diluted EPS: Three Months Ended Nine Months Ended November 4, 2016 October 30, 2015 November 4, 2016 October 30, 2015 (in millions) Antidilutive stock options excluded - 0.3 0.3 0.3

Scitor Acquisition

Scitor Acquisition	9 Months Ended
	Nov. 04, 2016
Business Combinations [Abstract]
Scitor Acquisition	Note 3—Scitor Acquisition: On May 4, 2015 the Company completed the acquisition of Scitor, a leading global provider of technical services to the U.S. intelligence community and other U.S. government customers. The acquisition was funded from cash on hand and increased borrowings. Purchase consideration paid to acquire Scitor was $764 million (net of cash acquired), including $43 million which was deposited to escrow accounts. In August 2015 $3 million was released from escrow to the sellers after finalizing the working capital adjustment and another $13 million was released in September 2016 that was held to secure a portion of the sellers’ indemnification obligations. Any remaining amount in escrow at the end of the indemnification period will be distributed to the sellers. The purchase price was allocated among assets acquired and liabilities assumed at fair value based on the best available information, with the excess purchase price recorded as goodwill. During the first quarter of fiscal 2017, the Company completed its review of Scitor’s historical government accounting practices and adjusted the preliminary purchase price allocation to recognize $5 million in additional liabilities for potential questioned costs under U.S. government Cost Accounting Standards (CAS) and $2 million of related deferred income tax assets resulting in a $3 million net increase to goodwill. The Company has completed the purchase accounting valuation for this transaction and recorded final purchase accounting entries as follows: (in millions) Cash and cash equivalents $ 39 Accounts receivable 86 Prepaid and other current assets 7 Deferred income taxes 12 Equipment and leasehold improvements 21 Intangible assets 255 Goodwill 484 Other noncurrent assets 1 Total assets acquired 905 Accounts payable and accrued liabilities 49 Accrued payroll and employee benefits 35 Other noncurrent liabilities 18 Total liabilities assumed 102 Net assets acquired $ 803 At the date of the acquisition, the tax deductible goodwill was $136 million and the tax deductible identified intangible assets were $163 million. The Company incurred $54 million in total costs associated with the acquisition and integration of Scitor. Acquisition-related expenses, all of which were incurred in prior fiscal years, were $28 million including $17 million of deferred financing fees. For the nine months ended November 4, 2016, the Company incurred $10 million of costs in connection with the integration of Scitor, primarily for facility consolidation and severance costs. There were no costs in connection with the integration of Scitor in the three months ended November 4, 2016. For the three and nine months ended October 30, 2015, costs incurred in connection with the integration of Scitor were $1 million and $6 million, respectively, which were primarily for strategic consulting services, facility consolidation, severance costs, and other integration-related costs. For the nine months ended October 30, 2015, acquisition-related expenses were $10 million and there were no acquisition-related expenses incurred in the three months ended October 30, 2015. These costs are included in acquisition and integration costs on the condensed and consolidated statements of income and comprehensive income. The following unaudited pro forma financial information presents the combined results of operations of Scitor and the Company for the three and nine months ended October 30, 2015: Three Months Ended Nine Months Ended October 30, 2015 October 30, 2015 (in millions, except per share amounts) Total revenues $ 1,136 $ 3,392 Net income $ 37 $ 105 Earnings per share: Basic $ 0.81 $ 2.29 Diluted $ 0.78 $ 2.21 The unaudited pro forma, combined financial information presented above has been prepared from historical financial statements that have been adjusted to give effect to the acquisition of Scitor as though it had occurred on February 1, 2014. They include adjustments for intangible asset amortization; interest expense and debt issuance costs on long-term debt; acquisition, integration, and other transaction costs; and the elimination of intercompany revenue and expenses.

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Nov. 04, 2016
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock-Based Compensation	Note 4—Stock-Based Compensation: Stock Options During the nine months ended November 4, 2016, the Company granted certain employees 0.3 million stock options with a weighted-average exercise price and weighted-average grant date fair value of $53.79 and $10.20, respectively. These options will expire on the seventh anniversary of the grant date and will vest ratably on each anniversary of the grant date over a three-year period. Restricted Stock Units (RSUs) During the nine months ended November 4, 2016, the Company granted certain employees 0.4 million RSUs with a weighted-average grant date fair value of $53.50, which will vest ratably on each anniversary of the grant date over a four-year period. Performance Shares During the nine months ended November 4, 2016, the Company granted to certain employees 0.1 million performance share awards with a grant date fair value of $53.34 per award. These awards will cliff vest at the end of the third fiscal year following the grant date, subject to meeting the minimum service requirements and the achievement of certain annual and cumulative financial metrics of the Company’s performance, with the number of shares ultimately issued, if any, ranging up to 150% of the specified target shares.

Income Taxes

Income Taxes	9 Months Ended
	Nov. 04, 2016
Income Tax Disclosure [Abstract]
Income Taxes	Note 5—Income Taxes: As of November 4, 2016, the balance of unrecognized tax benefits included liabilities for uncertainty in income taxes of $4 million, all of which is classified as other long-term liabilities on the condensed and consolidated balance sheets. While the Company believes it has adequate accruals for uncertainty in income taxes, the tax authorities, on review of the Company’s tax filings, may determine that the Company owes taxes in excess of recorded accruals, or the recorded accruals may be in excess of the final settlement amounts agreed to by tax authorities. Although the timing of such reviews is not certain, we do not believe that it is reasonably possible that the unrecognized tax benefits will materially change in the next 12 months. Provision for income taxes as a percentage of income before income taxes was 28.3% and 33.6% for the three and nine months ended November 4, 2016, respectively, and 32.1% and 37.5% for the three and nine months ended October 30, 2015, respectively. Tax rates for the three and nine months ended November 4, 2016 were lower than for the three and nine months ended October 30, 2015 primarily due to increased research and development credits in the current year. Tax rates for the periods ended November 4, 2016 were lower than the combined federal and state statutory rates due to permanent tax benefits, including the manufacturer’s tax deduction and research and development credits.

Debt Obligations

Debt Obligations	9 Months Ended
	Nov. 04, 2016
Debt Disclosure [Abstract]
Debt Obligations	Note 6—Debt Obligations: The Company’s long-term debt as of the dates presented was as follows: November 4, 2016 January 29, 2016 Stated interest rate Effective interest rate Principal Unamortized Debt Issuance Costs Net Principal Unamortized Debt Issuance Costs Net (in millions) Term Loan A Facility due August 2021 2.56 % 2.61 % $ 660 $ (3 ) $ 657 $ 551 $ (2 ) $ 549 Term Loan B Facility due May 2022 3.25 % 3.83 % 400 (11 ) 389 536 (15 ) 521 Total long-term debt $ 1,060 $ (14 ) $ 1,046 $ 1,087 $ (17 ) $ 1,070 Less current portion 8 - 8 57 - 57 Total long-term debt, net of current portion $ 1,052 $ (14 ) $ 1,038 $ 1,030 $ (17 ) $ 1,013 As of November 4, 2016, the Company has a $1.3 billion credit facility (the Credit Facility), which consists of a $200 million secured revolving credit facility (the Revolving Credit Facility), a $660 million secured term facility (Term Loan A Facility), and a $400 million secured term facility (Term Loan B Facility) (together, the Term Loan Facilities). The Revolving Credit Facility capacity is available to the Company through August 2021, but no draws have been made. On August 23, 2016, the Company amended the Second Amended and Restated Credit Agreement (Amendment) to extend the maturity of the Term Loan A Facility and the termination date of the Revolving Credit Facility to August 2021, and to transfer $132 million of principal outstanding under the Term Loan B Facility to the Term Loan A Facility. Further, the Amendment lowers the interest rate margins on the Revolving Credit Facility and the Term Loan Facilities, resets the Term Loan A Facility’s quarterly principal repayment schedule and eliminates the required quarterly principal repayments for the Term Loan B Facility. The Company recognized $5 million in expenses associated with the amendment, which is included in interest expense and includes $2 million in write-offs of unamortized debt issuance costs. The Company deferred an additional $2 million in financing fees that are amortized to interest expense utilizing the effective interest method. Borrowings under the Credit Facilities bear a variable rate of interest based on Eurocurrency Rate or Base Rate, plus applicable margin. Upon the effectiveness of the Amendment, the applicable margin with respect to Term Loan A Facility and borrowings under the Revolving Credit Facility ranges from 1.50% to 2.25% for Eurocurrency Rate loans, and 0.50% to 1.25% for Base Rate loans. Interest rate margins for the Term Loan B Facility under the Amendment are 2.50%, subject to a 0.75% floor for Eurocurrency Rate loans or 1.50% for Base Rate loans. Except for the Term Loan B Facility, the applicable margin and commitment fees will vary based on the Company’s leverage ratio. The Term Loan A Facility principal under the Amendment is repaid quarterly on the last business day The Credit Facility contains certain restrictive covenants applicable to the Company and its subsidiaries including a requirement to maintain a Senior Secured Leverage Ratio (as defined in the Second Amended and Restated Credit Agreement) of not greater than 4.00 to 1.00 until July 31, 2016, and not greater than 3.75 to 1.00 thereafter, and requires the Company to make an annual prepayment as a portion of its Excess Cash Flow (as defined in the Second Amended and Restated Credit Agreement). As of November 4, 2016 the Company was in compliance with the covenants under its Credit Facility. Maturities of long-term debt as of November 4, 2016 are: Fiscal Year Ending Total (in millions) Remainder of 2017 $ - 2018 16 2019 41 2020 58 2021 66 Thereafter 879 Total principal payments $ 1,060 As of November 4, 2016 and January 29, 2016, the carrying value of the Company’s outstanding debt obligations approximated its fair value. The fair value of long-term debt is calculated using Level 2 inputs, based on interest rates available for debt with terms and maturities similar to the Company’s Term Loan Facilities.

Derivative Instruments Designat

Derivative Instruments Designated as Cash Flow Hedges	9 Months Ended
	Nov. 04, 2016
Derivative Instruments And Hedging Activities Disclosure [Abstract]
Derivative Instruments Designated as Cash Flow Hedges	Note 7—Derivative Instruments Designated as Cash Flow Hedges: The Company’s derivative instruments designated as cash flow hedges consist of: Liability Fair Value (1) at Notional Amount at November 4, 2016 Pay Fixed Rate Receive Variable Rate Settlement and Termination November 4, 2016 January 29, 2016 (in millions) (in millions) Term loan A interest rate swaps $ 425 1.41 % 1-month LIBOR Monthly through September 26, 2018 $ 5 $ 7 Term loan B interest rate swaps 350 1.88 % 3-month LIBOR (2) Quarterly through May 7, 2020 8 8 Total $ 775 $ 13 $ 15 (1) The fair value of the fixed interest rate swaps liability is included in accounts payable and accrued liabilities on the condensed and consolidated balance sheets. (2) Subject to a 0.75% floor. The Company is party to fixed interest rate swap instruments that are designated and accounted for as cash flow hedges to manage risks associated with interest rate fluctuations on a portion of the Company’s floating rate debt. The counterparties to all swap agreements are financial institutions. See Note 8 for the effective portion of the unrealized change in fair values on cash flow hedges recognized in other comprehensive loss and the amounts reclassified from accumulated other comprehensive loss into earnings for the current and comparative periods presented. There was no ineffectiveness during any of the periods presented. The Company estimates that it will reclassify $6 million of unrealized losses from accumulated other comprehensive loss into earnings in the twelve months following November 4, 2016.

Changes in Accumulated Other Co

Changes in Accumulated Other Comprehensive Loss by Component	9 Months Ended
	Nov. 04, 2016
Equity [Abstract]
Changes in Accumulated Other Comprehensive Loss by Component	Note 8—Changes in Accumulated Other Comprehensive Loss by Component: The following table presents the changes in accumulated other comprehensive loss attributable to the Company’s fixed interest rate swap cash flow hedges that are discussed in Note 7. Unrealized Losses on Fixed Interest Rate Swap Cash Flow Hedges Pre-Tax Amount (1) Income Tax (2) Net Amount (in millions) Three months ended November 4, 2016 Balance at August 5, 2016 $ 14 $ (5 ) $ 9 Other comprehensive loss before reclassifications - - - Amounts reclassified from accumulated other comprehensive loss (2 ) - (2 ) Net other comprehensive income (2 ) - (2 ) Balance at November 4, 2016 $ 12 $ (5 ) $ 7 Three months ended October 30, 2015 Balance at July 31, 2015 $ 6 $ (2 ) $ 4 Other comprehensive loss before reclassifications 7 (3 ) 4 Amounts reclassified from accumulated other comprehensive loss (3 ) 1 (2 ) Net other comprehensive loss 4 (2 ) 2 Balance at October 30, 2015 $ 10 $ (4 ) $ 6 Nine months ended November 4, 2016 Balance at January 29, 2016 $ 14 $ (5 ) $ 9 Other comprehensive loss before reclassifications 4 (2 ) 2 Amounts reclassified from accumulated other comprehensive loss (6 ) 2 (4 ) Net other comprehensive income (2 ) - (2 ) Balance at November 4, 2016 $ 12 $ (5 ) $ 7 Nine months ended October 30, 2015 Balance at January 30, 2015 $ 8 $ (3 ) $ 5 Other comprehensive loss before reclassifications 9 (4 ) 5 Amounts reclassified from accumulated other comprehensive loss (7 ) 3 (4 ) Net other comprehensive loss 2 (1 ) 1 Balance at October 30, 2015 $ 10 $ (4 ) $ 6 (1) The amount reclassified from accumulated other comprehensive loss was included in interest expense. (2) The amount reclassified from accumulated other comprehensive loss was included in the provision for income taxes.

Legal Proceedings and Other Com

Legal Proceedings and Other Commitments and Contingencies	9 Months Ended
	Nov. 04, 2016
Commitments And Contingencies Disclosure [Abstract]
Legal Proceedings and Other Commitments and Contingencies	Note 9—Legal Proceedings and Other Commitments and Contingencies: Legal Proceedings The Company is involved in various claims and lawsuits arising in the normal conduct of its business, none of which the Company’s management believes, based on current information, is expected to have a material adverse effect on the Company’s financial position, results of operations or cash flows. Agreements with Former Parent The Company commenced its operations on September 27, 2013 (the Distribution Date) following completion of a tax-free spin-off transaction from its former parent company, Leidos Holdings, Inc. (formerly SAIC, Inc., collectively with its consolidated subsidiaries, “former Parent”). In the spin-off transaction, former Parent’s technical, engineering and enterprise IT services business was separated (the separation) into an independent, publicly traded company named Science Applications International Corporation (formerly SAIC Gemini, Inc.). Former Parent and the Company executed various agreements to provide mechanisms for an orderly transition and to govern certain ongoing relationships between the companies following the separation. The agreements include a Distribution Agreement, Employee Matters Agreement, Tax Matters Agreement, Master Transition Services Agreement, and Master Transitional Contracting Agreement (MTCA). These agreements generally provide that each party is responsible for its respective assets, liabilities and obligations, including employee benefits, insurance and tax-related assets and liabilities. The MTCA also governs the relationship between former Parent and the Company with regard to the treatment of contracts, proposals, and teaming arrangements where both companies are or will be jointly performing work after separation. Each of former Parent and the Company indemnify the other party for work performed by it under the MTCA. Contingent losses that were unknown at the time of separation and arise from the operation of the Company’s historical business or the former Parent’s historical corporate losses will be shared between the parties to the extent that losses in any such category exceed $50 million in the aggregate. If they arise and exceed the $50 million threshold, the Company will be responsible for 30% of the former Parent’s incremental contingent losses on corporate claims (and former Parent will be responsible for 70% of the Company’s incremental losses on claims relating to operations that exceed $50 million). Government Investigations, Audits and Reviews The Company is routinely subject to investigations and reviews relating to compliance with various laws and regulations with respect, in particular, to its role as a contractor to federal, state and local government customers and in connection with performing services in countries outside of the United States. U.S. government agencies, including the Defense Contract Audit Agency (DCAA), the Defense Contract Management Agency and others, routinely audit and review a contractor’s performance on government contracts, indirect rates and pricing practices, and compliance with applicable contracting and procurement laws, regulations and standards. They also review the adequacy of the contractor’s compliance with government standards for its business systems. Adverse findings in these investigations, audits, or reviews can lead to criminal, civil or administrative proceedings, and the Company could face disallowance of previously billed costs, penalties, fines, compensatory damages and suspension or debarment from doing business with governmental agencies. Due to the Company’s reliance on government contracts, adverse findings could also have a material impact on the Company’s business, including its financial position, results of operations and cash flows. The indirect cost audits by the DCAA of the Company’s business remain open for fiscal 2011 and subsequent years. Although the company has recorded contract revenues subsequent to and including fiscal 2011 based on an estimate of costs that the Company believes will be approved on final audit, the Company does not know the outcome of any ongoing or future audits. If future completed audit adjustments exceed the Company’s reserves for potential adjustments, the Company’s profitability could be materially adversely affected. The Company has recorded reserves for estimated net amounts to be refunded to customers for potential adjustments for indirect cost audits and compliance with Cost Accounting Standards, which include indemnification obligations owing to former Parent for periods prior to the Distribution Date. As of November 4, 2016, the Company has recorded a total liability of $38 million for estimated net amounts to be refunded to customers for potential adjustments from audits of contract costs. Any additional amounts which may be determined to be owed for periods prior to the separation will be allocated to former Parent and the Company in proportions determined in accordance with the Distribution Agreement. Army Brigade Combat Team Modernization Engineering, Manufacturing and Development (BCTM) Program The BCTM program was terminated for convenience by the Department of Defense (DoD) effective in September 2011. From October 2009 through termination, the Company and its prime contractor performed on this program under an undefinitized change order with a provision that allowed the Company to receive a provisional fixed fee (contract profit) lower than the estimated fixed fee due, pending completion of contract negotiations. The Company recognized revenues of approximately $480 million (including provisional fixed fee) from October 2009 through August 2013 under the undefinitized change order. The Company expects that acceptance of the final contract termination proposal will occur in the first half of fiscal 2018. The Company had an outstanding receivable of approximately $2 million on this contract as of November 4, 2016. Letters of Credit and Surety Bonds The Company has outstanding obligations relating to letters of credit of $9 million as of November 4, 2016, principally related to guarantees on insurance policies. The Company also has outstanding obligations relating to surety bonds in the amount of $18 million, principally related to performance and payment bonds on the Company’s contracts. The majority of the surety bonds outstanding were initially obtained by former Parent and the Company is required to satisfy these obligations under the terms of the Distribution Agreement.

Business Overview and Summary17

Business Overview and Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Nov. 04, 2016
Accounting Policies [Abstract]
Segment Reporting	Each of the Company’s operating segments is focused on providing the Company’s comprehensive technical and enterprise IT service offerings to its respective customer base. The Company’s operating segments have been aggregated into one reporting segment for financial reporting purposes.
Basis of Presentation	The accompanying financial information has been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission for interim reporting purposes. References to “financial statements” refer to the condensed and consolidated financial statements of the Company, which include the statements of income and comprehensive income, balance sheets, statement of equity and statements of cash flows. These financial statements were prepared in accordance with U.S. generally accepted accounting principles (GAAP). All intercompany transactions and account balances within the Company have been eliminated. The financial statements are unaudited, but in the opinion of management include all adjustments, which consist of normal recurring adjustments, necessary for a fair presentation thereof. The results reported in these financial statements are not necessarily indicative of results that may be expected for the entire year and should be read in conjunction with the information contained in the Company’s Annual Report on Form 10-K for the year ended January 29, 2016.
Use of Estimates	Use of Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingencies at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting periods. Significant estimates inherent in the preparation of the financial statements may include, but are not limited to estimated profitability of long-term contracts, income taxes, fair value measurements, fair value of goodwill and other intangible assets, and contingencies. Estimates have been prepared by management on the basis of the most current and best available information at the time of estimation and actual results could differ from those estimates. Changes in estimates of revenues, cost of revenues or profits related to contracts accounted for using the cost-to-cost and efforts expended methods of percentage-of-completion accounting are recognized in operating income in the period in which such changes are made for the inception-to-date effect of the changes. Changes in these estimates can routinely occur over the contract performance period for a variety of reasons, which include: changes in contract scope; changes in contract cost estimates due to unanticipated cost growth or reassessments of risks impacting costs; changes in estimated incentive or award fees; and performance being better or worse than previously estimated. Aggregate changes in contract estimates increased operating income by $5 million ($0.08 per diluted share) and $18 million ($0.26 per diluted share) for the three and nine months ended November 4, 2016, respectively, and increased operating income by $1 million ($0.02 per diluted share) and $9 million ($0.12 per diluted share) for the three and nine months ended October 30, 2015, respectively.
Reporting Periods	Reporting Periods The Company utilizes a 52/53 week fiscal year ending on the Friday closest to January 31, with fiscal quarters typically consisting of 13 weeks. Fiscal 2016 began on January 31, 2015 and ended on January 29, 2016, while fiscal 2017 began on January 30, 2016 and ends on February 3, 2017. The number of weeks for each quarter for fiscal 2017 and 2016 are as follows: Fiscal 2017 Fiscal 2016 (weeks) First Quarter 14 13 Second Quarter 13 13 Third Quarter 13 13 Fourth Quarter 13 13 Fiscal Year 53 52
Operating Cycle	Operating Cycle The Company’s operating cycle for long-term contracts may be greater than one year and is measured by the average time intervening between the inception and the completion of those contracts. Contract-related assets and liabilities are classified as current assets and current liabilities.
Derivative Instruments Designated as Cash Flow Hedges	Derivative Instruments Designated as Cash Flow Hedges Derivative instruments are recorded on the condensed and consolidated balance sheets at fair value. Unrealized gains and losses on derivatives designated as cash flow hedges are reported in other comprehensive (loss) income and reclassified to earnings in a manner that matches the timing of the earnings impact of the hedged transactions. The ineffective portion of all hedges, if any, is recognized immediately in earnings. The Company’s fixed interest rate swaps are considered over-the-counter derivatives, and fair value is calculated using a standard pricing model for interest rate swaps with contractual terms for maturities, amortization and interest rates. Level 2, or market observable inputs (such as yield and credit curves), are used within the standard pricing models in order to determine fair value. The fair value is an estimate of the amount that the Company would pay or receive as of a measurement date if the agreements were transferred to a third party or canceled. See Note 7 for further discussion on the Company’s derivative instruments designated as cash flow hedges.
Accounting Standards Updates	Accounting Standards Updates In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers (Topic 606) Deferral of the Effective Date In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) Topic 840 Revenue from Contracts with Customers (Topic 606) In March 2016, the FASB issued ASU No. 2016-09, Improvements to Employee Share-Based Payment Accounting In November 2016, the FASB issued ASU No. 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash Other Accounting Standards Updates effective after November 4, 2016 are not expected to have a material effect on the Company’s financial statements.
Earnings Per Share	Basic earnings per share (EPS) is computed by dividing net income by the basic weighted-average number of shares outstanding. Diluted EPS is computed similarly to basic EPS, except the weighted-average number of shares outstanding is increased to include the dilutive effect of outstanding stock options and other stock-based awards.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Nov. 04, 2016
Earnings Per Share [Abstract]
Reconciliation of Weighted Average Number of Shares Outstanding Used to Compute Basic and Diluted EPS	A reconciliation of the weighted-average number of shares outstanding used to compute basic and diluted EPS was: Three Months Ended Nine Months Ended November 4, 2016 October 30, 2015 November 4, 2016 October 30, 2015 (in millions) Basic weighted-average number of shares outstanding 44.2 46.0 44.6 45.9 Dilutive common share equivalents - stock options and other stock-based awards 1.4 1.4 1.4 1.6 Diluted weighted-average number of shares outstanding 45.6 47.4 46.0 47.5
Stock-Based Awards Excluded from Weighted Average Number of Shares Outstanding Used to Compute Diluted EPS	The following stock-based awards were excluded from the weighted-average number of shares outstanding used to compute diluted EPS: Three Months Ended Nine Months Ended November 4, 2016 October 30, 2015 November 4, 2016 October 30, 2015 (in millions) Antidilutive stock options excluded - 0.3 0.3 0.3

Scitor Acquisition (Tables)

Scitor Acquisition (Tables)	9 Months Ended
	Nov. 04, 2016
Business Combinations [Abstract]
Schedule of Purchase Price Allocated Among Assets Acquired and Liabilities Assumed	The purchase price was allocated among assets acquired and liabilities assumed at fair value based on the best available information, with the excess purchase price recorded as goodwill. During the first quarter of fiscal 2017, the Company completed its review of Scitor’s historical government accounting practices and adjusted the preliminary purchase price allocation to recognize $5 million in additional liabilities for potential questioned costs under U.S. government Cost Accounting Standards (CAS) and $2 million of related deferred income tax assets resulting in a $3 million net increase to goodwill. The Company has completed the purchase accounting valuation for this transaction and recorded final purchase accounting entries as follows: (in millions) Cash and cash equivalents $ 39 Accounts receivable 86 Prepaid and other current assets 7 Deferred income taxes 12 Equipment and leasehold improvements 21 Intangible assets 255 Goodwill 484 Other noncurrent assets 1 Total assets acquired 905 Accounts payable and accrued liabilities 49 Accrued payroll and employee benefits 35 Other noncurrent liabilities 18 Total liabilities assumed 102 Net assets acquired $ 803
Schedule of Unaudited Pro Forma Financial Information	The following unaudited pro forma financial information presents the combined results of operations of Scitor and the Company for the three and nine months ended October 30, 2015: Three Months Ended Nine Months Ended October 30, 2015 October 30, 2015 (in millions, except per share amounts) Total revenues $ 1,136 $ 3,392 Net income $ 37 $ 105 Earnings per share: Basic $ 0.81 $ 2.29 Diluted $ 0.78 $ 2.21

Debt Obligations (Tables)

Debt Obligations (Tables)	9 Months Ended
	Nov. 04, 2016
Debt Disclosure [Abstract]
Long Term Debt	The Company’s long-term debt as of the dates presented was as follows: November 4, 2016 January 29, 2016 Stated interest rate Effective interest rate Principal Unamortized Debt Issuance Costs Net Principal Unamortized Debt Issuance Costs Net (in millions) Term Loan A Facility due August 2021 2.56 % 2.61 % $ 660 $ (3 ) $ 657 $ 551 $ (2 ) $ 549 Term Loan B Facility due May 2022 3.25 % 3.83 % 400 (11 ) 389 536 (15 ) 521 Total long-term debt $ 1,060 $ (14 ) $ 1,046 $ 1,087 $ (17 ) $ 1,070 Less current portion 8 - 8 57 - 57 Total long-term debt, net of current portion $ 1,052 $ (14 ) $ 1,038 $ 1,030 $ (17 ) $ 1,013
Maturities of Long-term Debt	Maturities of long-term debt as of November 4, 2016 are: Fiscal Year Ending Total (in millions) Remainder of 2017 $ - 2018 16 2019 41 2020 58 2021 66 Thereafter 879 Total principal payments $ 1,060

Derivative Instruments Design21

Derivative Instruments Designated as Cash Flow Hedges (Tables)	9 Months Ended
	Nov. 04, 2016
Derivative Instruments And Hedging Activities Disclosure [Abstract]
Derivative Instruments Designated as Cash Flow Hedges	The Company’s derivative instruments designated as cash flow hedges consist of: Liability Fair Value (1) at Notional Amount at November 4, 2016 Pay Fixed Rate Receive Variable Rate Settlement and Termination November 4, 2016 January 29, 2016 (in millions) (in millions) Term loan A interest rate swaps $ 425 1.41 % 1-month LIBOR Monthly through September 26, 2018 $ 5 $ 7 Term loan B interest rate swaps 350 1.88 % 3-month LIBOR (2) Quarterly through May 7, 2020 8 8 Total $ 775 $ 13 $ 15 (1) The fair value of the fixed interest rate swaps liability is included in accounts payable and accrued liabilities on the condensed and consolidated balance sheets. (2) Subject to a 0.75% floor.

Changes in Accumulated Other 22

Changes in Accumulated Other Comprehensive Loss by Component (Tables)	9 Months Ended
	Nov. 04, 2016
Equity [Abstract]
Changes in Accumulated Other Comprehensive Loss Attributable to the Company's Fixed Interest Rate Swap Cash Flow Hedges	The following table presents the changes in accumulated other comprehensive loss attributable to the Company’s fixed interest rate swap cash flow hedges that are discussed in Note 7. Unrealized Losses on Fixed Interest Rate Swap Cash Flow Hedges Pre-Tax Amount (1) Income Tax (2) Net Amount (in millions) Three months ended November 4, 2016 Balance at August 5, 2016 $ 14 $ (5 ) $ 9 Other comprehensive loss before reclassifications - - - Amounts reclassified from accumulated other comprehensive loss (2 ) - (2 ) Net other comprehensive income (2 ) - (2 ) Balance at November 4, 2016 $ 12 $ (5 ) $ 7 Three months ended October 30, 2015 Balance at July 31, 2015 $ 6 $ (2 ) $ 4 Other comprehensive loss before reclassifications 7 (3 ) 4 Amounts reclassified from accumulated other comprehensive loss (3 ) 1 (2 ) Net other comprehensive loss 4 (2 ) 2 Balance at October 30, 2015 $ 10 $ (4 ) $ 6 Nine months ended November 4, 2016 Balance at January 29, 2016 $ 14 $ (5 ) $ 9 Other comprehensive loss before reclassifications 4 (2 ) 2 Amounts reclassified from accumulated other comprehensive loss (6 ) 2 (4 ) Net other comprehensive income (2 ) - (2 ) Balance at November 4, 2016 $ 12 $ (5 ) $ 7 Nine months ended October 30, 2015 Balance at January 30, 2015 $ 8 $ (3 ) $ 5 Other comprehensive loss before reclassifications 9 (4 ) 5 Amounts reclassified from accumulated other comprehensive loss (7 ) 3 (4 ) Net other comprehensive loss 2 (1 ) 1 Balance at October 30, 2015 $ 10 $ (4 ) $ 6 (1) The amount reclassified from accumulated other comprehensive loss was included in interest expense. (2) The amount reclassified from accumulated other comprehensive loss was included in the provision for income taxes.

Business Overview and Summary23

Business Overview and Summary of Significant Accounting Policies (Detail 1) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended
	Nov. 04, 2016USD ($)$ / shares	Oct. 30, 2015USD ($)$ / shares	Nov. 04, 2016USD ($)Segment$ / shares	Oct. 30, 2015USD ($)$ / shares	May 04, 2015
Significant Accounting Policies [Line Items]
Number of reportable segments | Segment			1
Increase (decrease) in operating income due to aggregate changes in contract estimates | $	$ 5	$ 1	$ 18	$ 9
Increase (decrease) in diluted earnings per share due to aggregate changes in contract estimates | $ / shares	$ 0.08	$ 0.02	$ 0.26	$ 0.12
Operating cycle (in years)			greater than one year
Scitor Holdings, Inc.
Significant Accounting Policies [Line Items]
Definitive agreement to acquire business, Percentage of acquisition					100.00%

Earnings Per Share (Detail 1)

Earnings Per Share (Detail 1) - shares shares in Millions	3 Months Ended		9 Months Ended
	Nov. 04, 2016	Oct. 30, 2015	Nov. 04, 2016	Oct. 30, 2015
Computation Of Earnings Per Share [Line Items]
Basic weighted-average number of shares outstanding	44.2	46	44.6	45.9
Dilutive common share equivalents - stock options and other stock-based awards	1.4	1.4	1.4	1.6
Diluted weighted-average number of shares outstanding	45.6	47.4	46	47.5
Stock Options
Computation Of Earnings Per Share [Line Items]
Total antidilutive stock-based awards	0	0.3	0.3	0.3

Scitor Acquisition (Detail 1)

Scitor Acquisition (Detail 1) - USD ($)	May 04, 2015	Sep. 30, 2016	Aug. 31, 2015	Nov. 04, 2016	May 06, 2016	Oct. 30, 2015	Nov. 04, 2016	Oct. 30, 2015	Nov. 04, 2016
Business Acquisition [Line Items]
Purchase consideration paid, net of cash acquired							$ 0	$ 764,000,000
Acquisition and integration costs				$ 0		$ 1,000,000	10,000,000	16,000,000
Deferred financing fees							$ 2,000,000	17,000,000
Scitor Holdings, Inc.
Business Acquisition [Line Items]
Date of acquisition							May 4, 2015
Purchase consideration paid, net of cash acquired	$ 764,000,000
Amount deposited to adjustment and indemnification escrow accounts included in cash consideration paid	43,000,000
Amount released from escrow account		$ 13,000,000	$ 3,000,000
Recognition of additional liabilities for potential questioned costs					$ 5,000,000
Deferred income tax assets					2,000,000
Net increase in goodwill					$ 3,000,000
Tax deductible goodwill	136,000,000
Tax deductible identified intangible assets	$ 163,000,000
Acquisition and integration costs									$ 54,000,000
Deferred financing fees									17,000,000
Acquisition expenses						0		10,000,000	$ 28,000,000
Integration costs				$ 0		$ 1,000,000	$ 10,000,000	$ 6,000,000

Scitor Acquisition (Detail 2)

Scitor Acquisition (Detail 2) - USD ($) $ in Millions	Nov. 04, 2016	Jan. 29, 2016	May 04, 2015
Business Acquisition [Line Items]
Goodwill	$ 863	$ 860
Scitor Holdings, Inc.
Business Acquisition [Line Items]
Cash and cash equivalents			$ 39
Accounts receivable			86
Prepaid and other current assets			7
Deferred income taxes			12
Equipment and leasehold improvements			21
Intangible assets			255
Goodwill			484
Other noncurrent assets			1
Total assets acquired			905
Accounts payable and accrued liabilities			49
Accrued payroll and employee benefits			35
Other noncurrent liabilities			18
Total liabilities assumed			102
Net assets acquired			$ 803

Scitor Acquisition (Detail 3)

Scitor Acquisition (Detail 3) - Scitor Holdings, Inc. - USD ($) $ / shares in Units, $ in Millions	3 Months Ended	9 Months Ended
	Oct. 30, 2015	Oct. 30, 2015
Business Acquisition [Line Items]
Total revenues	$ 1,136	$ 3,392
Net income	$ 37	$ 105
Earnings per share:
Basic	$ 0.81	$ 2.29
Diluted	$ 0.78	$ 2.21

Stock-Based Compensation (Detai

Stock-Based Compensation (Detail 1) shares in Millions	9 Months Ended
	Nov. 04, 2016$ / sharesshares
Employee Stock Option
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options granted | shares	0.3
Stock option weighted-average exercise price	$ 53.79
Weighted-average grant date fair value of options awarded	$ 10.20
Contractual term	7 years
Vesting period	3 years
Restricted Stock Units (RSUs)
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period	4 years
Awards granted | shares	0.4
Weighted-average grant date fair value	$ 53.50
Performance Shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period	3 years
Weighted-average grant date fair value	$ 53.34
Share awards granted | shares	0.1
Percentage of target shares	150.00%

Income Taxes (Detail 1)

Income Taxes (Detail 1) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Nov. 04, 2016	Oct. 30, 2015	Nov. 04, 2016	Oct. 30, 2015
Income Taxes [Line Items]
Effective income tax rate	28.30%	32.10%	33.60%	37.50%
Other Long-Term Liabilities
Income Taxes [Line Items]
Liabilities for uncertainty in income taxes	$ 4		$ 4

Debt Obligations (Detail 1)

Debt Obligations (Detail 1) - USD ($) $ in Millions	Nov. 04, 2016	Jan. 29, 2016
Debt Instrument [Line Items]
Principal amount of long-term debt	$ 1,060	$ 1,087
Principal amount of long-term debt, current	8	57
Principal amount of long-term debt, non current	1,052	1,030
Unamortized Debt Issuance Costs, long term debt	(14)	(17)
Unamortized Debt Issuance Costs, current	0	0
Unamortized Debt Issuance Costs, non current	(14)	(17)
Total long-term debt	1,046	1,070
Long-term debt, current portion (Note 6)	8	57
Long-term debt, net of current portion (Note 6)	$ 1,038	1,013
Term Loan A Facility due August 2021
Debt Instrument [Line Items]
Stated interest rate	2.56%
Effective interest rate	2.61%
Principal amount of long-term debt	$ 660	551
Unamortized Debt Issuance Costs, long term debt	(3)	(2)
Total long-term debt	$ 657	549
Term Loan B Facility due May 2022
Debt Instrument [Line Items]
Stated interest rate	3.25%
Effective interest rate	3.83%
Principal amount of long-term debt	$ 400	536
Unamortized Debt Issuance Costs, long term debt	(11)	(15)
Total long-term debt	$ 389	$ 521

Debt Obligations (Detail 2)

Debt Obligations (Detail 2)	Aug. 23, 2016USD ($)	Nov. 04, 2016USD ($)	Oct. 30, 2015USD ($)	Jul. 31, 2019	Jul. 31, 2018	Nov. 04, 2016USD ($)	Oct. 30, 2015USD ($)	Aug. 31, 2021	Jan. 29, 2016USD ($)
Debt Instrument [Line Items]
Credit facility, maximum borrowing capacity		$ 1,300,000,000				$ 1,300,000,000
Principal amount of long-term debt		1,060,000,000				1,060,000,000			$ 1,087,000,000
Interest expenses associated with the amendment		$ 15,000,000	$ 14,000,000			41,000,000	$ 31,000,000
Deferred financing fees						$ 2,000,000	$ 17,000,000
Second Amended and Restated Credit Agreement, as Amended on August 23, 2016
Debt Instrument [Line Items]
Interest expenses associated with the amendment	$ 5,000,000
Write-offs of unamortized debt issuance costs	2,000,000
Deferred financing fees	$ 2,000,000
Credit Agreement financial covenant, description						The Credit Facility contains certain restrictive covenants applicable to the Company and its subsidiaries including a requirement to maintain a Senior Secured Leverage Ratio (as defined in the Second Amended and Restated Credit Agreement) of not greater than 4.00 to 1.00 until July 31, 2016, and not greater than 3.75 to 1.00 thereafter, and requires the Company to make an annual prepayment as a portion of its Excess Cash Flow (as defined in the Second Amended and Restated Credit Agreement).
Second Amended and Restated Credit Agreement, as Amended on August 23, 2016 | Maximum | Until July 31, 2016
Debt Instrument [Line Items]
Credit Agreement financial covenant, leverage ratio		4				4
Second Amended and Restated Credit Agreement, as Amended on August 23, 2016 | Maximum | After July 31, 2016
Debt Instrument [Line Items]
Credit Agreement financial covenant, leverage ratio		3.75				3.75
Term Loan A Facility due August 2021
Debt Instrument [Line Items]
Principal amount of long-term debt		$ 660,000,000				$ 660,000,000			551,000,000
Term Loan A Facility due August 2021 | Second Amended and Restated Credit Agreement, as Amended on August 23, 2016
Debt Instrument [Line Items]
Debt instrument maturity period	2021-08
Transfer of principle outstanding from term loan B facility to term loan A facility	$ 132,000,000
Term Loan A Facility due August 2021 | Second Amended and Restated Credit Agreement, as Amended on August 23, 2016 | Scenario Forecast
Debt Instrument [Line Items]
Percentage of principal amount outstanding				1.875%	1.25%			2.50%
Term Loan A Facility due August 2021 | Second Amended and Restated Credit Agreement, as Amended on August 23, 2016 | Minimum | Eurocurrency Rate
Debt Instrument [Line Items]
Interest rate margin under credit agreement						1.50%
Term Loan A Facility due August 2021 | Second Amended and Restated Credit Agreement, as Amended on August 23, 2016 | Minimum | Base Rate
Debt Instrument [Line Items]
Interest rate margin under credit agreement						0.50%
Term Loan A Facility due August 2021 | Second Amended and Restated Credit Agreement, as Amended on August 23, 2016 | Maximum | Eurocurrency Rate
Debt Instrument [Line Items]
Interest rate margin under credit agreement						2.25%
Term Loan A Facility due August 2021 | Second Amended and Restated Credit Agreement, as Amended on August 23, 2016 | Maximum | Base Rate
Debt Instrument [Line Items]
Interest rate margin under credit agreement						1.25%
Term Loan B Facility due May 2022
Debt Instrument [Line Items]
Principal amount of long-term debt		400,000,000				$ 400,000,000			$ 536,000,000
Term Loan B Facility due May 2022 | Second Amended and Restated Credit Agreement, as Amended on August 23, 2016
Debt Instrument [Line Items]
Interest rate margin under credit agreement						2.50%
Term Loan B Facility due May 2022 | Second Amended and Restated Credit Agreement, as Amended on August 23, 2016 | Eurocurrency Rate
Debt Instrument [Line Items]
Debt instrument floor rate						0.75%
Term Loan B Facility due May 2022 | Second Amended and Restated Credit Agreement, as Amended on August 23, 2016 | Base Rate
Debt Instrument [Line Items]
Interest rate margin under credit agreement						1.50%
Revolving Credit Facility
Debt Instrument [Line Items]
Credit facility, maximum borrowing capacity		$ 200,000,000				$ 200,000,000
Revolving Credit Facility | Second Amended and Restated Credit Agreement, as Amended on August 23, 2016
Debt Instrument [Line Items]
Credit facility termination period	2021-08

Debt Obligations (Detail 3)

Debt Obligations (Detail 3) - USD ($) $ in Millions	Nov. 04, 2016	Jan. 29, 2016
Debt Disclosure [Abstract]
Remainder of 2017	$ 0
2,018	16
2,019	41
2,020	58
2,021	66
Thereafter	879
Principal amount of long-term debt	$ 1,060	$ 1,087

Derivative Instruments Design33

Derivative Instruments Designated as Cash Flow Hedges (Detail 1) - USD ($)		9 Months Ended
		Nov. 04, 2016	Jan. 29, 2016
Derivative [Line Items]
Notional Amount		$ 775,000,000
Liability Fair Value	[1]	13,000,000	$ 15,000,000
Term Loan A Facility | Interest Rate Swaps
Derivative [Line Items]
Notional Amount		$ 425,000,000
Pay Fixed Rate		1.41%
Receive Variable Rate		1-month LIBOR
Settlement and Termination		Monthly through September 26, 2018
Liability Fair Value	[1]	$ 5,000,000	7,000,000
Term Loan B Facility | Interest Rate Swaps
Derivative [Line Items]
Notional Amount		$ 350,000,000
Pay Fixed Rate		1.88%
Receive Variable Rate	[2]	3-month LIBOR
Settlement and Termination		Quarterly through May 7, 2020
Liability Fair Value	[1]	$ 8,000,000	$ 8,000,000
[1]	The fair value of the fixed interest rate swaps liability is included in accounts payable and accrued liabilities on the condensed and consolidated balance sheets.
[2]	Subject to a 0.75% floor.

Derivative Instruments Design34

Derivative Instruments Designated as Cash Flow Hedges (Parenthetical) (Detail 1)	Nov. 04, 2016
Interest Rate Swaps | Term Loan B Facility
Derivative [Line Items]
Derivative instrument floor rate	0.75%

Derivative Instruments Design35

Derivative Instruments Designated as Cash Flow Hedges (Detail 2) - Interest Rate Swaps - USD ($)	3 Months Ended		9 Months Ended
	Nov. 04, 2016	Oct. 30, 2015	Nov. 04, 2016	Oct. 30, 2015
Derivative [Line Items]
Unrealized losses estimated to be reclassified from accumulated other comprehensive loss into earnings in the next twelve months	$ 6,000,000		$ 6,000,000
Cash Flow Hedging
Derivative [Line Items]
Ineffective portion of the unrealized change in fair value, net of tax	$ 0	$ 0	$ 0	$ 0

Changes in Accumulated Other 36

Changes in Accumulated Other Comprehensive Loss by Component (Detail 1) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Nov. 04, 2016	Oct. 30, 2015	Nov. 04, 2016	Oct. 30, 2015
Accumulated Other Comprehensive Income Loss Net Of Tax [Abstract]
Unrealized Losses on Fixed Interest Rate Swap Cash Flow Hedges, Beginning Balance, Pre-Tax Amount	[1]	$ 14	$ 6	$ 14	$ 8
Unrealized Losses on Fixed Interest Rate Swap Cash Flow Hedges, Other comprehensive loss before reclassifications, Pre-Tax Amount	[1]	0	7	4	9
Unrealized Losses on Fixed Interest Rate Swap Cash Flow Hedges, Amounts reclassified from accumulated other comprehensive loss, Pre-Tax Amount	[1]	(2)	(3)	(6)	(7)
Unrealized Losses on Fixed Interest Rate Swap Cash Flow Hedges, Net other comprehensive loss (income), Pre-Tax Amount	[1]	(2)	4	(2)	2
Unrealized Losses on Fixed Interest Rate Swap Cash Flow Hedges, Ending Balance, Pre-Tax Amount	[1]	12	10	12	10
Unrealized Losses on Fixed Interest Rate Swap Cash Flow Hedges, Beginning Balance, Income Tax	[2]	(5)	(2)	(5)	(3)
Unrealized Losses on Fixed Interest Rate Swap Cash Flow Hedges, Other comprehensive loss before reclassifications, Income Tax	[2]	0	(3)	(2)	(4)
Unrealized Losses on Fixed Interest Rate Swap Cash Flow Hedges, Amounts reclassified from accumulated other comprehensive loss, Income Tax	[2]	0	1	2	3
Unrealized Losses on Fixed Interest Rate Swap Cash Flow Hedges, Net other comprehensive loss (income), Income Tax	[2]	0	(2)	0	(1)
Unrealized Losses on Fixed Interest Rate Swap Cash Flow Hedges, Ending Balance, Income Tax	[2]	(5)	(4)	(5)	(4)
Unrealized Losses on Fixed Interest Rate Swap Cash Flow Hedges, Beginning Balance, Net Amount		9	4	9	5
Unrealized Losses on Fixed Interest Rate Swap Cash Flow Hedges, Other comprehensive loss before reclassifications, Net Amount		0	4	2	5
Unrealized Losses on Fixed Interest Rate Swap Cash Flow Hedges, Amounts reclassified from accumulated other comprehensive loss, Net Amount		(2)	(2)	(4)	(4)
Unrealized Losses on Fixed Interest Rate Swap Cash Flow Hedges, Net other comprehensive loss (income), Net Amount		(2)	2	(2)	1
Unrealized Losses on Fixed Interest Rate Swap Cash Flow Hedges, Ending Balance, Net Amount		$ 7	$ 6	$ 7	$ 6
[1]	The amount reclassified from accumulated other comprehensive loss was included in interest expense.
[2]	The amount reclassified from accumulated other comprehensive loss was included in the provision for income taxes.

Legal Proceedings and Other C37

Legal Proceedings and Other Commitments and Contingencies (Detail 1) - USD ($)	3 Months Ended		9 Months Ended		45 Months Ended
	Nov. 04, 2016	Oct. 30, 2015	Nov. 04, 2016	Oct. 30, 2015	Aug. 02, 2013
Commitments And Contingencies [Line Items]
Contingent losses, loss sharing percentage in excess of threshold			30.00%
Loss contingency threshold for loss sharing, Description			Contingent losses that were unknown at the time of separation and arise from the operation of the Company’s historical business or the former Parent’s historical corporate losses will be shared between the parties to the extent that losses in any such category exceed $50 million in the aggregate. If they arise and exceed the $50 million threshold, the Company will be responsible for 30% of the former Parent’s incremental contingent losses on corporate claims (and former Parent will be responsible for 70% of the Company’s incremental losses on claims relating to operations that exceed $50 million).
Revenues	$ 1,114,000,000	$ 1,136,000,000	$ 3,424,000,000	$ 3,244,000,000
BCTM Program Termination
Commitments And Contingencies [Line Items]
Revenues					$ 480,000,000
Contracts receivable	2,000,000		$ 2,000,000
Government Investigations and Reviews
Commitments And Contingencies [Line Items]
Indirect cost audits, open fiscal year			2,011
Estimated net amounts to be refunded for potential adjustments	38,000,000		$ 38,000,000
Letters of Credit
Commitments And Contingencies [Line Items]
Outstanding obligations	9,000,000		9,000,000
Surety Bonds
Commitments And Contingencies [Line Items]
Outstanding obligations	$ 18,000,000		$ 18,000,000
Former Parent
Commitments And Contingencies [Line Items]
Contingent losses, loss sharing percentage in excess of threshold			70.00%
Former Parent | Minimum
Commitments And Contingencies [Line Items]
Contingent losses, threshold for loss sharing with former parent			$ 50,000,000